Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SyntheX

SyntheX
2016 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
6 INVESTORS
Description

Developer of a novel cell-based, synthetic biology-driven drug selection platform designed to provide efficient synthesis and identification of peptides and macrocycles. The company's platform discovers and designs drugs that target specific previously undruggable targets for therapeutic and biotechnological applications, enabling healthcare institutions to better serve human health.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 409 Illinois
  • San Francisco, CA 94158
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SyntheX’s full profile, request a free trial.

SyntheX Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 03-Jul-2018 00.00 Completed Pre-Clinical Trials
3. Seed Round 27-Apr-2017 00.000 00.00 000.00 Completed Pre-Clinical Trials
2. Accelerator/Incubator 27-Apr-2017 $350K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Mar-2016 $350K $350K Completed Product In Beta Test
To view this company’s complete deal history including valuation and funding, request access »

SyntheX Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

SyntheX Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IDEAYA Biosciences Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
000000 000000 Venture Capital-Backed South San Francisco, CA 0 00.00 000000000000 00.00
0000000 0000000000 Formerly VC-backed Cambridge, United Kingdom 00 00000 00000000 00000
000000 00000000000 Venture Capital-Backed Montreal, Canada 00 00000 00000000000 00000
00000000000 000000 Formerly VC-backed Newark, CA 00 00000 000000 - 000 00000
To view this company’s complete list of competitors, request access »

SyntheX Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
8VC Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
Morgan Noble Healthcare Partners PE/Buyout Minority 000 0000 000000 0
Oriza Ventures Venture Capital Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

SyntheX Executive Team (3)

Name Title Board
Seat
Contact
Info
Maria Soloveychik Ph.D Co-Founder, Chief Executive Officer & Board Member
Charly Chahwan Co-Founder, Chief Scientific Officer & Board Member
Tri Luong Head, Finance

SyntheX Board Members (3)

Name Representing Role Since Contact
Info
Arvind Gupta SOSV Board Member 000 0000
Charly Chahwan SyntheX Co-Founder, Chief Scientific Officer & Board Member 000 0000
Maria Soloveychik Ph.D SyntheX Co-Founder, Chief Executive Officer & Board Member 000 0000